Mirum Pharmaceuticals, Inc. MIRM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$23.36M+73.4% | -$87.94M+46.2% | -$163.42M-20.5% | -$135.67M— | ||
| $24.24M+2.6% | $23.63M+118% | $10.83M+234% | $3.24M+444% | ||
| $71.42M+47.4% | $48.44M+38.3% | $35.02M+29.7% | $27.01M+17.0% | ||
| $55.83M— | —— | -$70.94M+40.9% | -$120.14M+9.5% | ||
| $954K-3.9% | $993K— | —— | $278K+1,058% | ||
| -$24.96M+72.5% | -$90.77M+15.3% | -$107.2M-1,492% | $7.7M-84.1% | ||
| $40.14M+127% | $17.7M-94.7% | $336.6M+208% | $109.42M+48.9% | ||
| $75.24M+219% | -$63.4M— | —— | -$3.34M— | ||
| $54.87M— | —— | -$71.05M+41.0% | -$120.41M+9.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mirum Pharmaceuticals, Inc. generate?
- Mirum Pharmaceuticals, Inc. (MIRM) generated -$171.0M in operating cash flow over the trailing twelve months.
- What is Mirum Pharmaceuticals, Inc.'s free cash flow?
- After $1.6M of capital expenditures, Mirum Pharmaceuticals, Inc.'s free cash flow was -$172.6M over the trailing twelve months, down 45270.7% year over year.
- Where does Mirum Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
